162 related articles for article (PubMed ID: 16224816)
1. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice.
Marttila-Ichihara F; Castermans K; Auvinen K; Oude Egbrink MG; Jalkanen S; Griffioen AW; Salmi M
J Immunol; 2010 Mar; 184(6):3164-73. PubMed ID: 20154208
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
4. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.
Merinen M; Irjala H; Salmi M; Jaakkola I; Hänninen A; Jalkanen S
Am J Pathol; 2005 Mar; 166(3):793-800. PubMed ID: 15743791
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
6. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors.
Kiss J; Jalkanen S; Fülöp F; Savunen T; Salmi M
Eur J Immunol; 2008 Nov; 38(11):3041-9. PubMed ID: 18991279
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors.
Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M
Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345
[TBL] [Abstract][Full Text] [Related]
8. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1).
Arvilommi AM; Salmi M; Kalimo K; Jalkanen S
Eur J Immunol; 1996 Apr; 26(4):825-33. PubMed ID: 8625974
[TBL] [Abstract][Full Text] [Related]
10. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
Salmi M; Jalkanen S
Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
[TBL] [Abstract][Full Text] [Related]
11. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear.
Salmi M; Tohka S; Jalkanen S
Circ Res; 2000 Jun; 86(12):1245-51. PubMed ID: 10864915
[TBL] [Abstract][Full Text] [Related]
12. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes.
Salmi M; Hellman J; Jalkanen S
J Immunol; 1998 Jun; 160(11):5629-36. PubMed ID: 9605169
[TBL] [Abstract][Full Text] [Related]
13. A novel endothelial cell molecule mediating lymphocyte binding in humans.
Jalkanen S; Salmi M
Behring Inst Mitt; 1993 Aug; (92):36-43. PubMed ID: 8250815
[TBL] [Abstract][Full Text] [Related]
14. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
16. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo.
Tohka S; Laukkanen M; Jalkanen S; Salmi M
FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1).
Koskinen K; Vainio PJ; Smith DJ; Pihlavisto M; Ylä-Herttuala S; Jalkanen S; Salmi M
Blood; 2004 May; 103(9):3388-95. PubMed ID: 14726375
[TBL] [Abstract][Full Text] [Related]
18. Vascular adhesion protein-1 plays an important role in postischemic inflammation and neuropathology in diabetic, estrogen-treated ovariectomized female rats subjected to transient forebrain ischemia.
Xu HL; Salter-Cid L; Linnik MD; Wang EY; Paisansathan C; Pelligrino DA
J Pharmacol Exp Ther; 2006 Apr; 317(1):19-29. PubMed ID: 16339390
[TBL] [Abstract][Full Text] [Related]
19. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C
Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887
[TBL] [Abstract][Full Text] [Related]
20. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells.
Lalor PF; Edwards S; McNab G; Salmi M; Jalkanen S; Adams DH
J Immunol; 2002 Jul; 169(2):983-92. PubMed ID: 12097405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]